Leadership Team

David S. Perlin, Ph.D.

Executive Director, New Jersey Medical School (NJMS), Rutgers Biomedical and Health Sciences

Dr. David S. Perlin is a highly accomplished administrator and biomedical researcher. He is the inaugural Chief Scientific Officer for the Hackensack Meridian Health Center for Discovery and Innovation (CDI), which seeks to rapidly translate innovations in science to improve outcomes for patients with cancer, infectious diseases and autoimmune disorders.  Dr. Perlin has been engaged for >30 years in developing molecular insights and technologies to detect, combat and prevent drug resistant fungal, bacterial and viral infections.  In Mycology, his group has provided important insights about drivers and mechanisms of antifungal drug resistance, as well as molecular detection platforms.  Prior to joining CDI, he was Executive Director and Professor at the Rutgers New Jersey Medical School’s Public Health Research Institute and Director of the Rutgers Regional Biocontainment Laboratory (RBL), one of thirteen NIH-designated national centers for pathogen research. He has published more than 265 papers and book chapters and has co-authored two books. His laboratory is supported by multiple grants from the NIH, Pharma and biopharma sectors, and the NIH has continuously funded him for 30+ years. He currently leads an NIH-designated national Center of Excellence in Translational Research (CETR) to discover novel antibiotics against drug resistant bacterial infections.  During COVID-19, his group established a novel FDA EUA-approved COVID-19 molecular test; they performed detailed antibody profiles of recovered patients for convalescent therapy, and they are engaged in drug discovery against SARS-CoV-2 with Pharma and Biotech partners.  Dr. Perlin has served on advisory boards for the NIH, Bill & Melinda Gates Foundation, GAFFI, ADARC, and numerous Pharma, biotech and diagnostic companies.  He is also the founding Editor-in-Chief for the Journal of Fungi. Dr. Perlin is a Fellow of the American Academy of Microbiology (2018) and the New York Academy of Sciences (2006). He was named by RO1 a top 10 influencer in healthcare in New Jersey in 2019 and 2020; and 2020 Outstanding Scientist in New Jersey by the Edward J. Ill Excellence in Medicine Awards.

Back to Leadership Team